This approach has become the standard with GLP-1 and GIP receptor agonists because rapid introduction at high doses often leads to nausea, vomiting, or diarrhea severe enough for patients to discontinue treatment
The controversy surrounding whether a shorter treatment duration could lead to significant protection results may stem from the fact that the earlier study primarily enrolled patients in second-line diabetes treatments
like all therapies, GLP-1s can cause side effects including nausea, vomiting and other gastrointestinal issues
Zinc can actually reduce this conversion of testosterone into DHT and thus, reduce the symptoms associated with high testosterone levels
Proposed update of angiotensin receptor nomenclature
It affects approximately 10 percent of individuals of reproductive age and is a leading cause of chronic pelvic pain, dysmenorrhea, dyspareunia, and infertility